The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome

Alcohol and Alcoholism

Volumn 44, Issue 4, 2009, Pages 366-371

  Míguez Burbano, María José ^a   Lewis, John E ^b   Fishman, Joel ^b   Asthana, Deshratn ^b   Malow, Robert M ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; THYMUS; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VIRUS LOAD;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; THYMUS GLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67650233331     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agp024     Document Type: Article

References (43)

1. AIDSinfo: A service of US Department of Health and Human Services. (2003) Overview of guidelines. Available at http://www.aidsinfo.nih.gov/ guidelines. (16 May 2003, date last accessed)
2. Bryant KJ. (2006) Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse 41: 1465-1507.
3. Cayota A, Vuillier F, Gonzalez G et al. (1996) In vitro antioxidant treatment recovers proliferative responses of anergic CD4+ lymphocytes from human immunodeficiency virus-infected individuals. Blood 87:4746-53.
4. Chander G, Lau B, Moore RD. (2006) Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 43:411-7.
5. Chesney MA, Ickovics JR, Chambers DB et al. Patient Care Committee-Adherence Working Group of theOutcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 12: 255-66.
6. Conigliaro J, Gordon AJ, McGinnis KA et al. (2003) How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk? J Acquir Immune Defic Syndr 33 521-5.
7. Cook RL, Sereika SM, Hunt SC et al. (2001) Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 16:83-6.
8. DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. October 2004 revision. Available at http://aidsinfo.nih.gov/guidelines/adult/AA_040705.pdf.
9. + Jurkat T lymphocytes. J Lab Clin Med 136:333-43.
10. Douek DC, Vescio RA, Betts MR et al. (2000) Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355:1875-81.
11. Egger M, May M, Chene G et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 360:119-29.
12. Fabris P, Tositti G, Manfrin V et al. (2000) Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr 25:92-3.
13. Finucane MM, Samet JH, Horton NJ. (2007) Translational methods in biostatics: Linear mixed effects regression models of alcohol consumption and HIV disease progression over time. Epidemiol Perspect Innov 4:8.
14. Gaulton GN, Scobie JV, RosenzweigM. (1997) HIV-1 and the thymus. AIDS 11:403-14.
15. Giorgi JV, Cheng HL, Margolick JB et al. (1990) Quality control in the flow cytometric measurement of T-lymphocyte subsets. Clin Immunol Immunopathol 55:173-86.
16. Grønbæk M, Becker U, Johansen D et al. (2000) Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 133:411-19.
17. Grønbæk M, Deis A, Sørensen TI et al. (1995) Mortality associated with moderate intakes of wine, beer or spirits. BMJ 310:1165-9.
18. +) T-helper cells after human allogeneic bone marrow transplantation. Blood 90:850-7.
19. Hessol NA, Kalinowski A, Benning L et al. (2007) Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis 44:287-94.
20. Jacobson LP, Li R, Phair J et al. (2002) Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression. Am J Epidemiol 155:760-70.
21. Kotler DP. (1998) Antioxidant therapy and HIV infection. Am J Clin Nutr 67:7-9.
22. Lefevre F, O'Leary B, Moran M et al. (1995) Alcohol consumption among HIV-infected patients. J Gen Intern Med 10:458-60.
23. Míguez MJ, Lewis JE, Moreno J et al. (2008) Cognitive performance and the thymus among HIV infected subjects receiving HAART. J Biologics: Targets Ther 2:321-7.
24. Míguez MJ, Shor-Posner G. (2001) Alcohol use and HIV infection in the HAART era. Am Clin Lab, HIV Forum 20:20-3.
25. Míguez MJ, Shor-Posner G,Morales G et al. (2003) HIV treatment in drug abusers: Impact of alcohol use. Addict Biol 8:33-7.
26. Monahan CM, Padgett EL, Biber KL et al. (1997) Dose response to ethanol-containing liquid diets for use in a murine model for studies of biological effects due to ethanol consumption. Alcohol Clin Exp Res 21:1092-9.
27. National Institute on Alcohol Abuse and Alcoholism. (1995) The Physicians' Guide to Helping Patients with Alcohol Problems. Washington, DC: Government Printing Office,. Publication NIH 95, 3769.
28. Nicastri E, Leone S, Angeletti C et al. (2007) Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. J Antimicrob Chemother 60:724-32.
29. Nobile M, Correa R, Borghans JA et al. (2004) De novo T-cell generation in patients at different ages and stages of HIV-1 disease. Blood 104:470-7.
30. Prescott E, Grønbæk M, Becker U et al. (1999) Alcohol intake and the risk of lung cancer: Influence of type of alcoholic beverage. Am J Epidemiol 149:463-70.
31. Pruett SB, Fan R, Zheng Q et al. (2003) Modeling and predicting immunological effects of chemical stressors: Characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol Toxicol Sci 75:343-54.
32. Raju PA, Herzenberg L, Roedered M. (1994) Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothaizolidine carboxylate compared in vitro studies of HIV replication. AIDS Res Hum Retroviruses 10:961-7.
33. Reid M, Carrington Fiellin DA, O'Connor P. (1999) Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 159 1681-9.
34. Roeber J, Green DL, Meurer KM et al. (2007) Types of alcoholic beverages usually consumed by students in 9th-12th grades - four states, 2005. Morb Mortal Wkly Rep 56:737-40.
35. Roederer M, Staal FJT, Raju PA et al. (1990) Cytokine-stimulated human immunodeficiency virus replication is inhibited by N acetyl-L-cysteine. Proc Natl Acad Sci USA 87:4884-8.
36. Samet JH, Cheng DM, Libman H et al. (2007) Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 46: 194-9.
37. Samet JH, Horton NJ, Traphagen ET et al. (2003) Alcohol consumption and HIV disease progression: Are they related? Alcohol Clin Exp Res 27:862-7.
38. Shor-Posner G, Miguez MJ. (2001) Heavy alcohol use hinders HIV therapy: study. AIDS Alert 16:88-90.
39. Starkenburg S,Munroe ME,Waltenbaugh C. (2001) Early alteration in leukocyte populations and Th1/Th2 function in ethanol-consuming mice Alcohol Clin Exp Res 25:1221-30.
40. Teixeira L, Valdez H, McCune JM et al.(2001) Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15:1749-56.
41. Truelsen T, Grønbæk M, Schnohr P et al. (1998) Intake of beer, wine, and spirits and risk of stroke: The Copenhagen City Heart Study. Stroke 29:2467-72.
42. Wang X, Douglas SD, Metzger DS et al. (2002) Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res 26:1880-6.
43. Wang J, Spitzer J. (1997) Alcohol-induced thymocyte apoptosis is accompanied by impaired mitochondrial function. Alcohol 14: 99-105.